Recent advances in diagnostic strategies for giant cell arteritis

Current Neurology and Neuroscience Reports

Volumn 12, Issue 2, 2012, Pages 138-144

  Kermani, Tanaz A ^a   Warrington, Kenneth J ^a  

^a Mayo Clinic   (United States)

Author keywords

Computed tomography angiography; Diagnosis; Giant cell arteritis; Large vessel vasculitis; Magnetic resonance angiography; Positron emission Tomography; Temporal arteritis; Temporal artery biopsy; Ultrasonography

Indexed keywords

C REACTIVE PROTEIN;

ARTICLE; BLOOD VESSEL BIOPSY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; DIPLOPIA; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; GIANT CELL ARTERITIS; HEADACHE; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; MAGNETIC RESONANCE ANGIOGRAPHY; MEDICAL HISTORY; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; TEMPORAL ARTERITIS; TEMPORAL ARTERY BIOPSY;

AGED; BIOPSY; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; DIAGNOSTIC IMAGING; GIANT CELL ARTERITIS; HUMANS; MIDDLE AGED;

EID: 84861233643     PISSN: 15284042     EISSN: 15346293     Source Type: Journal    
DOI: 10.1007/s11910-011-0243-6     Document Type: Article

References (51)

1. Salvarani C, Cantini F, Hunder GG: Polymyalgia rheumatica and giant-cell arteritis. Lancet. 2008;372:234-45. (Pubitemid 351997438)
2. Kermani TA, Schafer VS, Crowson CS, et al. Increase in age at onset of giant cell arteritis: a population-based study. Ann Rheum Dis. 2010;69:780-1.
3. Gonzalez-Gay MA, Vazquez-Rodriguez TR, Lopez-Diaz MJ, et al.: Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum. 2009;61:1454-61.
4. Crowson CS, Matteson EL, Myasoedova E, et al.: The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum. 2011;63:633-9.
5. Aiello PD, Trautmann JC, McPhee TJ, et al. Visual prognosis in giant cell arteritis. Ophthalmology. 1993;100:550-5. (Pubitemid 23120705)
6. Salvarani C, Cimino L, Macchioni P, et al. Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis. Arthritis Rheum. 2005;53:293-7. (Pubitemid 40530172)
7. Gonzalez-Gay MA, Garcia-Porrua C, Llorca J, et al. Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients. Medicine (Baltimore). 2000;79:283-92.
8. Nuenninghoff DM, Hunder GG, Christianson TJ, et al. Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum. 2003;48:3522-31. (Pubitemid 37531919)
9. Kermani TA, Matteson EL, Hunder GG, Warrington KJ: Symptomatic lower extremity vasculitis in giant cell arteritis: a case series. The Journal of rheumatology. 2009;36:2277-83.
10. Nuenninghoff DM, Hunder GG, Christianson TJ, et al. Mortality of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a populationbased study over 50 years. Arthritis Rheum. 2003;48:3532-7. (Pubitemid 37531920)
11. Proven A, Gabriel SE, Orces C, et al. Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes. Arthritis Rheum. 2003;49:703-8. (Pubitemid 37296477)
12. Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33:1122-8. (Pubitemid 20273297)
13. Brack A, Martinez-Taboada V, Stanson A, et al. Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum. 1999;42:311-7. (Pubitemid 29072849)
14. Schmidt WA, Moll A, Seifert A, et al. Prognosis of large-vessel giant cell arteritis. Rheumatology (Oxford). 2008;47:1406-8.
15. Schmidt WA, Natusch A, Moller DE, et al. Involvement of peripheral arteries in giant cell arteritis: a color Doppler sonography study. Clin Exp Rheumatol. 2002;20:309-18. (Pubitemid 35012564)
16. Blockmans D, Stroobants S, Maes A, Mortelmans L. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med. 2000;108:246-9. (Pubitemid 30100617)
17. Agard C, Barrier JH, Dupas B, et al.: Aortic involvement in recent-onset giant cell (temporal) arteritis: a case-control prospective study using helical aortic computed tomodensitometric scan. Arthritis Rheum. 2008;59:670-6. (Pubitemid 351679542)
18. Aschwanden M, Kesten F, Stern M, et al. Vascular involvement in patients with giant cell arteritis determined by duplex sonography of 2x11 arterial regions. Ann Rheum Dis. 2010;69:1356-9.
19. Smetana GW, Shmerling RH. Does this patient have temporal arteritis? JAMA. 2002;287:92-101. (Pubitemid 34251681)
20. Younge BR, Cook Jr BE, Bartley GB, et al. Initiation of glucocorticoid therapy: before or after temporal artery biopsy? Mayo Clin Proc. 2004;79:483-91. (Pubitemid 38401768)
21. Walvick MD, Walvick MP. Giant Cell Arteritis: Laboratory Predictors of a Positive Temporal Artery Biopsy. Ophthalmology. 2011;118:1201-4.
22. Kyle V, Cawston TE, Hazleman BL. Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up. Ann Rheum Dis. 1989;48:667-71. (Pubitemid 19201965)
23. Pountain GD, Calvin J, Hazleman BL. Alpha 1-antichymotrypsin, Creactive protein and erythrocyte sedimentation rate in polymyalgia rheumatica and giant cell arteritis. Br J Rheumatol. 1994;33:550-4.
24. Myklebust G, Gran JT. A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis. Br J Rheumatol. 1996;35:1161-8.
25. Parikh M, Miller NR, Lee AG, et al. Prevalence of a normal Creactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis. Ophthalmology. 2006;113:1842-5. (Pubitemid 44442440)
26. Achkar AA, Lie JT, Hunder GG, et al. How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis? Ann Intern Med. 1994;120:987-92. (Pubitemid 24169277)
27. Ray-Chaudhuri N, Kine DA, Tijani SO, et al. Effect of prior steroid treatment on temporal artery biopsy findings in giant cell arteritis. Br J Ophthalmol. 2002;86:530-2. (Pubitemid 34454497)
28. Salvarani C, Crowson CS, O'Fallon WM, et al. Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period. Arthritis Rheum. 2004;51:264-8. (Pubitemid 38468712)
29. Niederkohr RD, Levin LA.ABayesian analysis of the true sensitivity of a temporal artery biopsy. Invest Ophthalmol Vis Sci. 2007;48:675-80. (Pubitemid 351260700)
30. Taylor-Gjevre R, Vo M, Shukla D, Resch L. Temporal artery biopsy for giant cell arteritis. J Rheumatol. 2005;32:1279-82. (Pubitemid 40995383)
31. Mahr A, Saba M, Kambouchner M, et al. Temporal artery biopsy for diagnosing giant cell arteritis: the longer, the better? Ann Rheum Dis. 2006;65:826-8. (Pubitemid 43799187)
32. Dasgupta B. Concise guidance: diagnosis and management of giant cell arteritis. Clin Med. 2010;10:381-6.
33. Ponge T, Barrier JH, Grolleau JY, et al. The efficacy of selective unilateral temporal artery biopsy versus bilateral biopsies for diagnosis of giant cell arteritis. J Rheumatol. 1988;15:997-1000.
34. Boyev LR, Miller NR, Green WR. Efficacy of unilateral versus bilateral temporal artery biopsies for the diagnosis of giant cell arteritis. Am J Ophthalmol. 1999;128:211-5. (Pubitemid 29379775)
35. Danesh-Meyer HV, Savino PJ, Eagle Jr RC, et al. Low diagnostic yield with second biopsies in suspected giant cell arteritis. J Neuroophthalmol. 2000;20:213-5.
36. Pless M, Rizzo 3rd JF. Lamkin JC, Lessell S: Concordance of bilateral temporal artery biopsy in giant cell arteritis. J Neuroophthalmol. 2000;20:216-8.
37. Breuer GS, Nesher G, Nesher R. Rate of discordant findings in bilateral temporal artery biopsy to diagnose giant cell arteritis. J Rheumatol. 2009;36:794-6.
38. Blockmans D, Bley T, Schmidt W: Imaging for large-vessel vasculitis. Current opinion in rheumatology. 2009;21:19-28.
39. Schmidt WA, Kraft HE, Vorpahl K, et al. Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med. 1997;337:1336-42. (Pubitemid 27467767)
40. Karassa FB, Matsagas MI, Schmidt WA, Ioannidis JP. Metaanalysis: test performance of ultrasonography for giant-cell arteritis. Ann Intern Med. 2005;142:359-69. (Pubitemid 40293409)
41. Karahaliou M, Vaiopoulos G, Papaspyrou S, et al. Colour duplex sonography of temporal arteries before decision for biopsy: a prospective study in 55 patients with suspected giant cell arteritis. Arthritis Res Ther. 2006;8:R116.
42. Schmidt WA, Seifert A, Gromnica-Ihle E, et al.: Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis. Rheumatology (Oxford). 2008;47:96-101. (Pubitemid 350286272)
43. Bley TA, Uhl M, Carew J, et al. Diagnostic value of highresolution MR imaging in giant cell arteritis. AJNR Am J Neuroradiol. 2007;28:1722-7. (Pubitemid 47598147)
44. Bley TA, Reinhard M, Hauenstein C, et al. Comparison of duplex sonography and high-resolution magnetic resonance imaging in the diagnosis of giant cell (temporal) arteritis. Arthritis Rheum. 2008;58:2574-8.
45. Yamada I, Nakagawa T, Himeno Y, et al. Takayasu arteritis: diagnosis with breath-hold contrast-enhanced three-dimensional MR angiography. J Magn Reson Imaging. 2000;11:481-7. (Pubitemid 30252834)
46. Kawasaki A, Michel P, Maeder P, Borruat FX. Visualizing the skip lesions of giant cell arteritis with CT arteriography. Eur Neurol. 2009;61:374.
47. Lefebvre C, Rance A, Paul JF, et al. The role of B-mode ultrasonography and electron beam computed tomography in evaluation of Takayasu's arteritis: a study of 43 patients. Semin Arthritis Rheum. 2000;30:25-32. (Pubitemid 30644070)
48. Chung JW, Kim HC, Choi YH, et al. Patterns of aortic involvement in Takayasu arteritis and its clinical implications: evaluation with spiral computed tomography angiography. J Vasc Surg. 2007;45:906-14. (Pubitemid 46656326)
49. Brodmann M, Lipp RW, Passath A, et al. The role of 2-18 Ffluoro- 2-deoxy-D-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries. Rheumatology (Oxford). 2004;43:241-2. (Pubitemid 38219684)
50. Lehmann P, Buchtala S, Achajew N, et al. 18 F-FDG PET as a diagnostic procedure in large vessel vasculitis-a controlled, blinded re-examination of routine PETscans. Clin Rheumatol. 2011;30:37-42.
51. Besson FL, Parienti JJ, Bienvenu B, et al.: Diagnostic performance of (18)F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2011;38:1764-72.